调查APOE基因型对细胞内胆固醇和老化老鼠大脑内内分泌系统的影响
Sherida M de Leeuw1,2, Tal Nuriel1,2
1Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, 630 West 168 Street, New York, NY 10032, USA.
bioRxiv : the preprint server for biology
|November 26, 2025
概括
阿波利波蛋白E4 (APOE4) 基因型影响大脑的胆固醇处理和内分泌功能,特别是在女性中,这可能解释了阿尔茨海默病风险的增加.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿波利波蛋白E (APOE) 基因型,特别是e4等位基因 (APOE4),是阿尔茨海默病 (AD) 的主要遗传风险因素.
- 除了粉样蛋白和蛋白病理之外,APOE4与AD风险的关联背后的机制尚未完全阐明.
- APOE影响细胞胆固醇贩运,这一过程对神经元功能至关重要,可能与AD病变产生有关.
研究的目的:
- 研究APOE基因型,性别和衰老对小鼠大脑细胞内胆固醇处理和内分泌系统的影响.
- 为了确定APOE如何影响内分泌体内胆固醇局部化.
- 为了确定与APOE基因型相关的胆固醇平衡的潜在性别特异性和年龄依赖性变化.
主要方法:
- 利用一种新的胆固醇结合探针 (D4H*-mCherry) 来量化细胞内胆固醇水平.
- 评估了早期内基因组 (Rab5),晚期内基因组 (CD63) 和 lysosomes (LAMP1) 的丰富性.
- 在具有APOE2,APOE3和APOE4基因型的年轻,中年和老年小鼠中,研究了在不同大脑区域 (皮质,海马体,内腔皮质) 的内溶性体与内溶性体的胆固醇局部化.
主要成果:
- 衰老,性别和APOE基因型诱导了细胞内胆固醇和内分泌体系统功能的区域特异性改变.
- 年轻的APOE4小鼠在早期/晚期内体中显示出降低的胆固醇,但增加了 lysosomes,这表明胆固醇处理受损.
- 性别显著改变了这些效应;老雌性APOE4小鼠在海马体和脑内皮层中显示出高解体胆固醇,这表明受性敏感性.
结论:
- APOE的基因型,年龄和性别相互作用,对内分泌体胆固醇稳定性进行调节.
- 雌性APOE4小鼠表现出最显著的内分泌体胆固醇失调.
- 早期,特定区域的内分泌体缺陷可能会导致与APOE4相关的AD风险升高,特别是在女性中.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


